• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Routine MRI Shows Reduced Callosal Length and Optic Sheath in Multiple Sclerosis

by
November 12, 2026
in Health
Reading Time: 7 mins read
0
Routine MRI Shows Reduced Callosal Length and Optic Sheath in Multiple Sclerosis

Routine MRI Shows Reduced Callosal Length and Optic Sheath in Multiple Sclerosis

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A retrospective case-control investigation evaluating routine magnetic resonance imaging scans has demonstrated that individuals diagnosed with multiple sclerosis exhibit measurable structural alterations in both the corpus callosum and the bilateral optic nerve sheath compared with healthy control subjects. The study, conducted by researchers at a single medical institution in an Indian cohort and published in the Egyptian Journal of Radiology and Nuclear Medicine, revealed that patients living with multiple sclerosis presented with statistically significant reductions in total corpus callosum length, callosal splenium thickness, and bilateral optic nerve sheath diameter. Concurrently, the multiple sclerosis cohort displayed greater thickness in the callosal genu and body regions relative to the healthy individuals, a morphometric contrast that diverged from several previously published investigations documenting generalized callosal atrophy. While standard magnetic resonance imaging sequences successfully captured these macroscopic white matter differences across the study participants without requiring specialized post-processing software packages, receiver operating characteristic curve analyses revealed that the discriminatory power of these individual callosal and optic sheath measurements remained constrained, indicating that such quantitative anatomical parameters cannot serve as standalone diagnostic biomarkers for the condition.

Multiple sclerosis represents a chronic, immune-mediated demyelinating pathology of the human central nervous system defined pathologically by persistent neuroinflammation, localized myelin destruction, and progressive neuroaxonal degeneration across cerebral pathways. The progressive disease process frequently involves the brain parenchymal architecture, the spinal cord, and the optic nerve pathways, culminating in diverse structural impairments and chronic functional neurological deficits. Over recent years, clinical neuroscience research has placed notable emphasis on the neuroimaging characterization of two specific anatomical regions: the corpus callosum and the optic nerve sheath. Within the intracranial vault, the corpus callosum functions as the largest white matter commissural tract connecting the left and right cerebral hemispheres, playing a fundamental role in coordinating interhemispheric communication. Owing to its exceptionally dense myelination, this extensive fiber bundle remains highly vulnerable to focal demyelination, secondary axonal transection, and regional tissue loss throughout the natural course of multiple sclerosis, rendering callosal morphometry a practical metric on conventional magnetic resonance imaging. Similarly, the optic nerve constitutes a delicate white matter fiber bundle less than three millimeters in diameter traversing posterior to the optic chiasm, carrying all retinal visual stimuli toward the cerebral cortex.

Because clinical optic neuritis represents one of the most recognized and prevalent initial presentations of demyelinating disease, chronic optic nerve involvement frequently causes progressive axonal loss that manifests as an observable reduction in optic nerve sheath diameter on clinical cross-sectional imaging. Although advanced neuroimaging sequences including volumetric whole-brain acquisitions and diffusion tensor imaging have demonstrated subtle microstructural abnormalities in demyelinating lesions, conventional routine magnetic resonance imaging continues to serve as the primary, globally accessible modality for diagnostic evaluation and longitudinal patient monitoring in routine clinical practice. Prior medical literature has described both callosal atrophy and optic nerve thinning independently; however, few empirical investigations have systematically evaluated both white matter structures simultaneously through conventional imaging sequences within an Indian demographic cohort. To address this clinical research question, the investigators formulated a retrospective case-control design intended to directly quantify callosal dimensions and optic nerve sheath diameters on routine scans from individuals diagnosed with multiple sclerosis and neurologically intact healthy control subjects, while also examining whether these quantitative morphometric dimensions exhibited identifiable associations with chronological patient age.

The retrospective study sample comprised a total of 196 participants between the ages of 18 and 78 years, divided equally into a cohort of 98 patients with confirmed multiple sclerosis and an asymptomatic comparison group of 98 healthy controls. Healthy subjects were retrospectively identified from existing institutional magnetic resonance imaging records based on the documented absence of known neurological disease or intracranial pathology. In the clinical cohort, participants with verified multiple sclerosis diagnoses and technically adequate brain imaging were enrolled, whereas individuals exhibiting excessive motion degradation, inadequate image resolution, or coexisting major intracranial or neurological conditions were excluded from the analysis. The sample size calculation was performed in advance utilizing nMaster version 2.0 software to ensure ninety percent statistical power alongside a five percent significance threshold. All diagnostic neuroimaging examinations were executed on a single 1.5 Tesla Siemens MAGNETOM Avanto scanner situated within the participating institution. However, because the study relied on retrospective archival clinical datasets, scanning protocols were not prospectively standardized between the diagnostic cohorts, resulting in distinct technical acquisition parameters across the patient and control groups.

For the multiple sclerosis patient cohort, scanning sequences included sagittal T2-weighted short tau inversion recovery, abbreviated as STIR, along with axial T1-weighted imaging. The sagittal T2-weighted STIR sequence operated with a repetition time of 9000 milliseconds, an echo time of 92 milliseconds, a slice thickness of 5 millimeters with an interslice spacing of 1.5 millimeters, and a field of view of 230 millimeters, while the axial T1-weighted sequence utilized a repetition time of 650 milliseconds, an echo time of 32 milliseconds, a slice thickness of 3 millimeters with zero spacing, and a field of view of 250 millimeters. In contrast, the control group protocol consisted of axial T1-weighted turbo spin echo sequences using a repetition time of 550 milliseconds, an echo time of 30 milliseconds, a 5-millimeter slice thickness with 1-millimeter spacing, and a 230-millimeter field of view, paired with sagittal T2-weighted turbo spin echo sequences employing a repetition time of 5000 milliseconds, an echo time of 104 milliseconds, a 5-millimeter slice thickness, and a 230-millimeter field of view. The investigators noted that technical differences in sequence selection, slice thickness, and acquisition spacing between the cohorts represented important procedural factors that could influence anatomical boundary visualization and manual measurement precision.

Morphometric measurements were obtained manually using the integrated electronic measurement scale provided by the magnetic resonance imaging operating system. The overall length of the corpus callosum was delineated on midsagittal T2-weighted images by establishing a linear caliper running from the inferior margin of the anterior genu to the inferior margin of the posterior splenium. Regional callosal thicknesses—specifically targeting the genu, callosal body, and splenium—were measured along planes perpendicular to the regional long axis of the callosal arch. Concurrently, bilateral optic nerve sheath diameters were evaluated on axial T1-weighted images at a standardized anatomical level positioned exactly three millimeters posterior to the ocular globe, oriented perpendicular to the longitudinal axis of each optic nerve. Statistical evaluations were performed with SPSS version 29, expressing quantitative continuous data as means accompanied by standard deviations or medians with interquartile ranges, and reporting categorical parameters as percentages. Independent sample t-tests compared dimensional parameters between the cohorts and examined differences across sexes, while Karl Pearson correlation coefficients evaluated associations between anatomical measurements and chronological age, with statistical significance established at a p-value threshold below 0.05.

Quantitative comparisons demonstrated statistically significant morphometric disparities between the multiple sclerosis and healthy control cohorts across all measured callosal and orbital dimensions. Patients diagnosed with multiple sclerosis presented with a significantly shorter mean corpus callosum length of 7.04 ± 0.46 centimeters, alongside a significantly reduced mean splenium thickness of 1.04 ± 0.19 centimeters, compared to healthy individuals. Furthermore, optic nerve assessments revealed that patients with multiple sclerosis displayed significantly smaller bilateral optic nerve sheath diameters, averaging 0.33 ± 0.06 centimeters in the right orbit and 0.33 ± 0.06 centimeters in the left orbit. Conversely, healthy control participants exhibited significantly smaller mean thicknesses within the anterior genu, measuring 1.09 ± 0.21 centimeters, and within the callosal body, measuring 0.51 ± 0.09 centimeters, than the multiple sclerosis cohort. The unexpected finding of increased genu and body thicknesses in multiple sclerosis patients occurred despite documented reductions in total callosal length and splenium thickness, presenting an anatomical contrast to earlier research that described generalized callosal thinning. The authors suggested that manual slice selection, slight variations in imaging plane orientation, partial-volume averaging, measurement placement, disease phenotype, and unadjusted demographic differences might have contributed to these regional thickness findings.

Sex-stratified subgroup analyses yielded further anatomical differences within the cohorts, each of which comprised 66 female participants and 32 male participants. In the multiple sclerosis cohort, male patients exhibited slightly greater overall callosal lengths, genu thicknesses, body thicknesses, and splenium dimensions than female patients, with statistically significant sex-based differences confirmed in corpus callosum length, genu thickness, and right optic nerve sheath diameter. Body thickness, splenium thickness, and left optic nerve sheath diameter did not differ significantly between sexes in the patient group. In addition, male multiple sclerosis patients demonstrated significantly lower mean right and left optic nerve sheath diameters compared to female patients. In contrast, the evaluation of the 98 healthy control subjects revealed no statistically significant differences between male and female participants across any callosal dimension or optic nerve sheath measurement, with all comparative p-values exceeding the 0.05 threshold. The authors noted that sex-related structural variations observed in callosal morphology among multiple sclerosis patients might partly reflect normal physiological variability in cranial architecture rather than exclusively representing disease-specific pathogenic mechanisms.

Analysis of chronological age associations using Karl Pearson correlation coefficients revealed diverging patterns between healthy individuals and individuals with multiple sclerosis. In the healthy control group, chronological age demonstrated a statistically significant negative correlation with callosal genu thickness (r = −0.37, p = 0.001) and a significant correlation with body thickness (r = 0.11, p = 0.003), whereas correlations between age and callosal length (r = 0.11, p = 0.27), splenium thickness (r = −0.30, p = 0.87), left optic nerve sheath diameter (r = 0.02, p = 0.002), and right optic nerve sheath diameter (r = 0.19, p = 0.06) did not attain conventional significance. In the multiple sclerosis cohort, chronological age showed no statistically significant correlation with any measured anatomical parameter, including corpus callosum length (r = 0.02, p = 0.86), genu thickness (r = −0.14, p = 0.19), body thickness (r = −0.08, p = 0.42), splenium thickness (r = −0.07, p = 0.91), left optic nerve sheath diameter (r = 0.01, p = 0.48), or right optic nerve sheath diameter (r = −0.06, p = 0.551). Receiver operating characteristic curves evaluating the diagnostic utility of these measurements in multiple sclerosis yielded area under the curve values ranging between 0.16 and 0.69. Callosal body thickness and genu thickness achieved the highest performance with areas under the curve of 0.69 and 0.66, respectively; however, because acceptable clinical diagnostics typically demand values exceeding 0.80, these morphometric variables demonstrated limited standalone discriminatory capacity.

The investigators emphasized several important methodological limitations inherent in their retrospective single-center study design that must guide the clinical interpretation of these findings. Manual anatomical measurements were executed without formal interobserver or intraobserver reproducibility assessments, introducing potential variability in caliper placement. A noticeable demographic imbalance was present, as the multiple sclerosis group had a significantly older mean age of 46.74 ± 15.91 years compared to 33.34 ± 10.51 years in the control group (p < 0.001), yet the retrospective framework did not incorporate prospective age-matching or multivariable statistical adjustments for demographic covariates. Furthermore, detailed clinical records regarding historical optic neuritis episodes, visual acuity, clinical phenotype, expanded disability scores, disease duration, and specific therapeutic interventions were unavailable, precluding any definitive determination of clinical correlation or causal relationships. Additionally, differences between the 3-millimeter and 5-millimeter slice thicknesses across acquisition sequences could have influenced manual boundary delineation. Consequently, the authors concluded that while routine magnetic resonance morphometry of the corpus callosum and optic nerve sheath captures informative macrostructural alterations in multiple sclerosis, these measurements should be viewed as descriptive, complementary imaging markers alongside established radiological criteria rather than independent diagnostic biomarkers, pending validation by prospective multicenter investigations featuring standardized acquisitions, reproducibility testing, and comprehensive clinical profiling.

Subject of Research: Magnetic resonance imaging morphometry of the corpus callosum and optic nerve sheath in multiple sclerosis

Article Title: Morphometric assessment of the corpus callosum and optic nerve using magnetic resonance imaging in patients with multiple sclerosis: a retrospective case–control study

Article References: B. K, N., & M. M, J. (2026). Morphometric assessment of the corpus callosum and optic nerve using magnetic resonance imaging in patients with multiple sclerosis: a retrospective case–control study. Egyptian Journal of Radiology and Nuclear Medicine, 57(1), Article 245. https://doi.org/10.1186/s43055-026-01905-x

Image Credits: AI Generated

DOI: 10.1186/s43055-026-01905-x

Keywords: multiple sclerosis, corpus callosum, optic nerve sheath diameter, magnetic resonance imaging, neuroimaging, case-control study, callosal morphometry, splenium thickness, genu thickness, white matter pathology, demyelinating disease, receiver operating characteristic, area under the curve, optic neuritis, neuroaxonal degeneration, radiological biomarkers, retrospective study

News Source: Ophelia Keating. (November 12, 2026). Routine MRI Shows Reduced Callosal Length and Optic Sheath in Multiple Sclerosis. Scienmag.

Tags: area under the curvecallosal morphometrycase-control studycorpus callosumdemyelinating diseasegenu thicknessmagnetic resonance imagingMultiple Sclerosisneuroaxonal degenerationneuroimagingoptic nerve sheath diameteroptic neuritisradiological biomarkersreceiver operating characteristicRetrospective studysplenium thicknesswhite matter pathology
Share12Tweet7Share2ShareShareShare1

Related Posts

Multi-Omics Analysis Links Ferroptosis to Diabetes-Induced Erectile Dysfunction

Multi-Omics Analysis Links Ferroptosis to Diabetes-Induced Erectile Dysfunction

November 16, 2026
Higher-Calorie Refeeding Accelerates Paediatric Weight Gain Without Increasing Refeeding Syndrome Risk

Higher-Calorie Refeeding Accelerates Paediatric Weight Gain Without Increasing Refeeding Syndrome Risk

November 16, 2026

Sustained Higher Body Mass Index Linked to Elevated Uterine Fibroid Risk

November 16, 2026

Dynamic Cognitive Models Improve External Dementia Transition Predictions But Face Major Limits

November 16, 2026

POPULAR NEWS

  • Attention Graph Model Improves Dynamic Anomaly Detection Across Six Datasets

    Attention Graph Model Improves Dynamic Anomaly Detection Across Six Datasets

    29 shares
    Share 12 Tweet 7
  • Blockchain-Integrated Machine Learning Enhances Fraud Detection in Supply Chain Networks

    29 shares
    Share 12 Tweet 7
  • Dynamic Cognitive Models Improve External Dementia Transition Predictions But Face Major Limits

    29 shares
    Share 12 Tweet 7
  • Binary Hippopotamus Optimization Achieves High Accuracy Across Sixteen Cancer Datasets

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Random Forest Outperforms CART in Mapping Land Cover Across Ajmer Region

Multi-Omics Analysis Links Ferroptosis to Diabetes-Induced Erectile Dysfunction

Symbiotic Co-Cultures and Milk Powder Fortification Enhance Functional Fermented Goat Milk

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 87 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.